Medtronic PLC (MDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtronic PLC (MDT) has a cash flow conversion efficiency ratio of 0.051x as of April 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.57 Billion) by net assets ($50.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MDT market cap for the company's overall valuation and market capitalisation.
Medtronic PLC - Cash Flow Conversion Efficiency Trend (1990–2026)
This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency. Explore MDT cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Equinor ASA
OL:EQNR
|
0.494x |
|
DBS GROUP ADR/4 SD 1
F:DEV
|
N/A |
|
Hon Hai Precision Industry Co Ltd
TW:2317
|
0.141x |
|
FAST RETAIL. CO. ADR 1/10
F:FR70
|
0.073x |
|
BP p.l.c
MX:BPN
|
0.142x |
|
Accenture plc
NYSE:ACN
|
0.115x |
|
Starbucks Corporation
NASDAQ:SBUX
|
-0.214x |
|
SK Square Co Ltd
KO:402340
|
0.003x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2026)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2026. View Medtronic PLC (MDT) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-04-30 | $50.07 Billion | $7.33 Billion | 0.146x | +0.29% |
| 2025-04-30 | $48.26 Billion | $7.04 Billion | 0.146x | +8.44% |
| 2024-04-30 | $50.42 Billion | $6.79 Billion | 0.135x | +15.16% |
| 2023-04-30 | $51.66 Billion | $6.04 Billion | 0.117x | -16.11% |
| 2022-04-30 | $52.72 Billion | $7.35 Billion | 0.139x | +15.22% |
| 2021-04-30 | $51.60 Billion | $6.24 Billion | 0.121x | -14.96% |
| 2020-04-30 | $50.87 Billion | $7.23 Billion | 0.142x | +1.90% |
| 2019-04-30 | $50.21 Billion | $7.01 Billion | 0.140x | +51.41% |
| 2018-04-30 | $50.82 Billion | $4.68 Billion | 0.092x | -32.46% |
| 2017-04-30 | $50.42 Billion | $6.88 Billion | 0.136x | +35.54% |
| 2016-04-30 | $51.83 Billion | $5.22 Billion | 0.101x | +9.33% |
| 2015-04-30 | $53.23 Billion | $4.90 Billion | 0.092x | -63.89% |
| 2014-04-30 | $19.44 Billion | $4.96 Billion | 0.255x | -2.48% |
| 2013-04-30 | $18.67 Billion | $4.88 Billion | 0.262x | +0.12% |
| 2012-04-30 | $17.11 Billion | $4.47 Billion | 0.261x | +11.49% |
| 2011-04-30 | $15.97 Billion | $3.74 Billion | 0.234x | -17.03% |
| 2010-04-30 | $14.63 Billion | $4.13 Billion | 0.282x | -6.42% |
| 2009-04-30 | $12.85 Billion | $3.88 Billion | 0.302x | -0.22% |
| 2008-04-30 | $11.54 Billion | $3.49 Billion | 0.302x | +11.44% |
| 2007-04-30 | $10.98 Billion | $2.98 Billion | 0.271x | +15.35% |
| 2006-04-30 | $9.38 Billion | $2.21 Billion | 0.235x | -12.80% |
| 2005-04-30 | $10.45 Billion | $2.82 Billion | 0.270x | -13.94% |
| 2004-04-30 | $9.08 Billion | $2.85 Billion | 0.314x | +19.28% |
| 2003-04-30 | $7.91 Billion | $2.08 Billion | 0.263x | +6.30% |
| 2002-04-30 | $6.43 Billion | $1.59 Billion | 0.247x | -25.62% |
| 2001-04-30 | $5.51 Billion | $1.83 Billion | 0.332x | +43.29% |
| 2000-04-30 | $4.49 Billion | $1.04 Billion | 0.232x | +86.22% |
| 1999-04-30 | $3.65 Billion | $455.30 Million | 0.125x | -63.26% |
| 1998-04-30 | $2.04 Billion | $693.10 Million | 0.339x | +27.71% |
| 1997-04-30 | $1.75 Billion | $463.60 Million | 0.265x | -5.09% |
| 1996-04-30 | $1.79 Billion | $500.50 Million | 0.280x | -3.56% |
| 1995-04-30 | $1.33 Billion | $387.20 Million | 0.290x | -14.39% |
| 1994-04-30 | $1.05 Billion | $356.90 Million | 0.339x | -2.20% |
| 1993-04-30 | $841.50 Million | $291.50 Million | 0.346x | +82.24% |
| 1992-04-30 | $796.50 Million | $151.40 Million | 0.190x | +2.58% |
| 1991-04-30 | $683.20 Million | $126.60 Million | 0.185x | -6.13% |
| 1990-04-30 | $541.00 Million | $106.80 Million | 0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardiovert… Read more